https://www.prnewswire.com/news-releases/hansa-biopharma-announces-70-million-non-dilutive-product-finance-transaction-with-novaquest-to-support-continued-development-of-the-companys-antibody-cleaving-enzyme-technology-platform-301588530.html
Hansa Biopharma announces $70 million non-dilutive product finance transaction with NovaQuest to...
Proceeds will be mainly utilized to: - Further strengthen the Company's position in kidney transplantation through the continued support of ongoing European...
https://portalnovaquestautonegociador2.azurewebsites.net/Home/Redirection
NovaQuest - NovaQuest